Wockhardt Limited (NSE:WOCKPHARMA)
India
· Delayed Price · Currency is INR 1,546.60
+36.60 (2.42%)
Jun 10, 2025, 3:30 PM IST
Wockhardt Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 30,120 | 27,980 | 26,510 | 32,300 | 27,080 | Upgrade
|
| Other Revenue | - | 320 | 60 | - | - | Upgrade
|
| Revenue | 30,120 | 28,300 | 26,570 | 32,300 | 27,080 | Upgrade
|
| Revenue Growth (YoY) | 6.43% | 6.51% | -17.74% | 19.28% | -4.78% | Upgrade
|
| Cost of Revenue | 11,320 | 12,320 | 11,720 | 13,490 | 12,100 | Upgrade
|
| Gross Profit | 18,800 | 15,980 | 14,850 | 18,810 | 14,980 | Upgrade
|
| Selling, General & Admin | 6,510 | 6,298 | 6,380 | 7,509 | 7,930 | Upgrade
|
| Other Operating Expenses | 8,320 | 7,662 | 7,390 | 8,321 | 7,660 | Upgrade
|
| Operating Expenses | 17,000 | 16,190 | 16,280 | 18,300 | 18,050 | Upgrade
|
| Operating Income | 1,800 | -210 | -1,430 | 510 | -3,070 | Upgrade
|
| Interest Expense | -2,540 | -2,910 | -2,920 | -2,820 | -2,430 | Upgrade
|
| Interest & Investment Income | - | 60 | 40 | 60 | 210 | Upgrade
|
| Currency Exchange Gain (Loss) | -40 | 18.6 | 796 | 108.6 | -21.4 | Upgrade
|
| Other Non Operating Income (Expenses) | 620 | -138.6 | -96 | -158.6 | -38.6 | Upgrade
|
| EBT Excluding Unusual Items | -160 | -3,180 | -3,610 | -2,300 | -5,350 | Upgrade
|
| Merger & Restructuring Charges | - | - | -130 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -1,310 | 280 | - | 950 | Upgrade
|
| Asset Writedown | - | -140 | - | - | -1,420 | Upgrade
|
| Other Unusual Items | - | 430 | -2,780 | -1,810 | 140 | Upgrade
|
| Pretax Income | -160 | -4,200 | -6,240 | -4,110 | -5,680 | Upgrade
|
| Income Tax Expense | 410 | 520 | -30 | -1,320 | -2,710 | Upgrade
|
| Earnings From Continuing Operations | -570 | -4,720 | -6,210 | -2,790 | -2,970 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | 9,850 | Upgrade
|
| Net Income to Company | -570 | -4,720 | -6,210 | -2,790 | 6,880 | Upgrade
|
| Minority Interest in Earnings | 100 | 90 | 620 | 350 | -20 | Upgrade
|
| Net Income | -470 | -4,630 | -5,590 | -2,440 | 6,860 | Upgrade
|
| Net Income to Common | -470 | -4,630 | -5,590 | -2,440 | 6,860 | Upgrade
|
| Shares Outstanding (Basic) | 156 | 144 | 144 | 121 | 120 | Upgrade
|
| Shares Outstanding (Diluted) | 156 | 144 | 144 | 121 | 120 | Upgrade
|
| Shares Change (YoY) | 7.89% | 0.13% | 19.50% | 0.35% | 8.51% | Upgrade
|
| EPS (Basic) | -3.02 | -32.10 | -38.80 | -20.24 | 57.10 | Upgrade
|
| EPS (Diluted) | -3.02 | -32.10 | -38.80 | -20.24 | 57.09 | Upgrade
|
| Free Cash Flow | -1,160 | 1,600 | 1,110 | 2,950 | -3,680 | Upgrade
|
| Free Cash Flow Per Share | -7.45 | 11.09 | 7.71 | 24.47 | -30.63 | Upgrade
|
| Gross Margin | 62.42% | 56.47% | 55.89% | 58.24% | 55.32% | Upgrade
|
| Operating Margin | 5.98% | -0.74% | -5.38% | 1.58% | -11.34% | Upgrade
|
| Profit Margin | -1.56% | -16.36% | -21.04% | -7.55% | 25.33% | Upgrade
|
| Free Cash Flow Margin | -3.85% | 5.65% | 4.18% | 9.13% | -13.59% | Upgrade
|
| EBITDA | 3,970 | 1,390 | 420 | 2,260 | -1,430 | Upgrade
|
| EBITDA Margin | 13.18% | 4.91% | 1.58% | 7.00% | -5.28% | Upgrade
|
| D&A For EBITDA | 2,170 | 1,600 | 1,850 | 1,750 | 1,640 | Upgrade
|
| EBIT | 1,800 | -210 | -1,430 | 510 | -3,070 | Upgrade
|
| EBIT Margin | 5.98% | -0.74% | -5.38% | 1.58% | -11.34% | Upgrade
|
| Revenue as Reported | 30,740 | 28,810 | 27,730 | 32,500 | 28,400 | Upgrade
|
Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.